{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T16:51:48Z","timestamp":1792515108436,"version":"4.5.0"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,1,5]],"date-time":"2016-01-05T00:00:00Z","timestamp":1451952000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007449","name":"Takeda Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007449","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemistry and Biophysics Reports"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1016\/j.bbrep.2016.01.001","type":"journal-article","created":{"date-parts":[[2016,1,8]],"date-time":"2016-01-08T02:15:20Z","timestamp":1452219320000},"page":"259-265","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["A proline-type fullerene derivative inhibits adipogenesis by preventing PPAR\u03b3 activation"],"prefix":"10.1016","volume":"5","author":[{"given":"Megumi","family":"Funakoshi-Tago","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Hattori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumihito","family":"Ueda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Tago","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoyuki","family":"Ohe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadahiko","family":"Mashino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroomi","family":"Tamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrep.2016.01.001_bib1","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/1741-7015-9-48","article-title":"Metabolic syndrome: definitions and controversies","volume":"9","author":"Kassi","year":"2011","journal-title":"BMC Med."},{"key":"10.1016\/j.bbrep.2016.01.001_bib2","doi-asserted-by":"crossref","first-page":"55","DOI":"10.7326\/0003-4819-119-7_Part_2-199310011-00006","article-title":"Medical hazards of obesity","volume":"119","author":"Pi-Sunyer","year":"1993","journal-title":"Ann. Intern Med."},{"key":"10.1016\/j.bbrep.2016.01.001_bib3","doi-asserted-by":"crossref","first-page":"e1001436","DOI":"10.1371\/journal.pbio.1001436","article-title":"The fat controller: adipocyte development","volume":"10","author":"Stephens","year":"2012","journal-title":"PLoS Biol."},{"key":"10.1016\/j.bbrep.2016.01.001_bib4","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1038\/nrm3198","article-title":"Forming functional fat: a growing understanding of adipocyte differentiation","volume":"12","author":"Cristancho","year":"2011","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.bbrep.2016.01.001_bib5","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1101\/gad.3.9.1323","article-title":"Differentiation-induced gene expression in 3T3-L1 preadipocytes: CCAAT\/enhancer binding protein interacts with and activates the promoters of two adipocyte-specific genes","volume":"3","author":"Christy","year":"1989","journal-title":"Genes Dev."},{"key":"10.1016\/j.bbrep.2016.01.001_bib6","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1101\/gad.5.9.1538","article-title":"Regulated expression of three C\/EBP isoforms during adipose conversion of 3T3-L1 cells","volume":"5","author":"Cao","year":"1991","journal-title":"Genes Dev."},{"key":"10.1016\/j.bbrep.2016.01.001_bib7","doi-asserted-by":"crossref","first-page":"4128","DOI":"10.1128\/MCB.16.8.4128","article-title":"Induction of peroxisome proliferator-activated receptor gamma during the conversion of 3T3 fibroblasts into adipocytes is mediated by C\/EBPbeta, C\/EBPdelta, and glucocorticoids","volume":"16","author":"Wu","year":"1996","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.bbrep.2016.01.001_bib8","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1146\/annurev.bi.64.070195.002021","article-title":"Transcriptional regulation of gene expression during adipocyte differentiation","volume":"64","author":"MacDougald","year":"1995","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.bbrep.2016.01.001_bib9","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1101\/gad.8.10.1224","article-title":"mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer","volume":"8","author":"Tontonoz","year":"1994","journal-title":"Genes Dev."},{"key":"10.1016\/j.bbrep.2016.01.001_bib10","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1074\/jbc.271.2.1138","article-title":"Regulation of GLUT4 gene expression by arachidonic acid. evidence for multiple pathways, one of which requires oxidation to prostaglandin E2","volume":"271","author":"Long","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrep.2016.01.001_bib11","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/318162a0","article-title":"C60: buckminsterfullerene","volume":"318","author":"Kroto","year":"1985","journal-title":"Nature"},{"key":"10.1016\/j.bbrep.2016.01.001_bib12","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1002\/cber.19931260829","article-title":"Cyclopropanierung von Fullerenen","volume":"126","author":"Bingel","year":"1993","journal-title":"Chem. Ber."},{"key":"10.1016\/j.bbrep.2016.01.001_bib13","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1039\/a700080d","article-title":"[60] Fullerene chemistry for materials science applications","volume":"7","author":"Prato","year":"1997","journal-title":"J. Mater. Chem."},{"key":"10.1016\/j.bbrep.2016.01.001_bib14","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1272\/jnms.79.248","article-title":"Water-soluble fullerene derivatives for drug discovery","volume":"79","author":"Nakamura","year":"2012","journal-title":"J. Nippon Med. Sch."},{"key":"10.1016\/j.bbrep.2016.01.001_bib15","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.3109\/10715760903273849","article-title":"Pyrrolidinium-type fullerene derivative-induced apoptosis by the generation of reactive oxygen species in HL-60 cells","volume":"43","author":"Nishizawa","year":"2009","journal-title":"Free. Radic. Res."},{"key":"10.1016\/j.bbrep.2016.01.001_bib16","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1016\/j.cellsig.2012.06.014","article-title":"Fullerene derivative prevents cellular transformation induced by JAK2 V617F mutant through inhibiting c-Jun N-terminal kinase pathway","volume":"24","author":"Funakoshi-Tago","year":"2012","journal-title":"Cell Signal."},{"key":"10.1016\/j.bbrep.2016.01.001_bib17","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/0960-894X(96)00064-9","article-title":"Superoxide radical quenching and cytochrome C peroxidase-like activity of C60-dimalonic acid, C62(COOH)4","volume":"6","author":"Okuda","year":"1996","journal-title":"Bioorgan. Med. Chem. Lett."},{"key":"10.1016\/j.bbrep.2016.01.001_bib18","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1080\/10641220009351404","article-title":"Synthesis of Various Water-Soluble G60 Derivatives and Their Superoxide-Quenching Activity","volume":"8","author":"Okuda","year":"2000","journal-title":"Fuller Sci. Technol."},{"key":"10.1016\/j.bbrep.2016.01.001_bib19","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/j.bmcl.2004.12.030","article-title":"Human immunodeficiency virus-reverse transcriptase inhibition and hepatitis C virus RNA-dependent RNA polymerase inhibition activities of fullerene derivatives","volume":"15","author":"Mashino","year":"2005","journal-title":"Bioorgan. Med. Chem. Lett."},{"issue":"9","key":"10.1016\/j.bbrep.2016.01.001_bib20","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1016\/j.cellsig.2008.05.013","article-title":"TRAF6 is a critical signal transducer in IL-33 signaling pathway","volume":"20","author":"Funakoshi-Tago","year":"2008","journal-title":"Cell Signal."},{"key":"10.1016\/j.bbrep.2016.01.001_bib21","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1248\/bpb.b14-00378","article-title":"Coffee inhibits adipocyte differentiation via inactivation of PPAR\u03b3","volume":"37","author":"Aoyagi","year":"2014","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.bbrep.2016.01.001_bib22","doi-asserted-by":"crossref","first-page":"e66337","DOI":"10.1371\/journal.pone.0066337","article-title":"Anti-influenza activity of c60 fullerene derivatives","volume":"8","author":"Shoji","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.bbrep.2016.01.001_bib23","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1016\/j.freeradbiomed.2011.05.026","article-title":"Highly hydroxylated fullerene localizes at the cytoskeleton and inhibits oxidative stress in adipocytes and a subcutaneous adipose-tissue equivalent","volume":"51","author":"Xiao","year":"2011","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.bbrep.2016.01.001_bib24","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/nature05485","article-title":"Inflammation and metabolic disorders","volume":"444","author":"Hotamisligil","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.bbrep.2016.01.001_bib25","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.diff.2008.09.009","article-title":"New aspects of adipogenesis: radicals and oxidative stress","volume":"77","author":"Gummersbach","year":"2009","journal-title":"Differentiation"},{"key":"10.1016\/j.bbrep.2016.01.001_bib26","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/S1097-2765(03)00391-5","article-title":"Coordination of p300-mediated chromatin remodeling and TRAP\/mediator function through coactivator PGC-1alpha","volume":"12","author":"Wallberg","year":"2003","journal-title":"Mol. Cell."},{"key":"10.1016\/j.bbrep.2016.01.001_bib27","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1046\/j.1440-1711.2000.00921.x","article-title":"Peroxisome proliferator-activated receptors in tumorigenesis: targets of tumour promotion and treatment","volume":"78","author":"Roberts-Thomson","year":"2000","journal-title":"Immunol. Cell. Biol."},{"key":"10.1016\/j.bbrep.2016.01.001_bib28","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/S1097-2765(00)80047-7","article-title":"Terminal differentiation of human breast cancer through PPAR gamma","volume":"1","author":"Mueller","year":"1998","journal-title":"Mol. Cell."},{"key":"10.1016\/j.bbrep.2016.01.001_bib29","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0248-4900(01)01178-9","article-title":"Expression of peroxisome proliferator-activated receptors alpha and gamma in differentiating human colon carcinoma Caco-2 cells","volume":"94","author":"Huin","year":"2002","journal-title":"Biol. Cell."},{"key":"10.1016\/j.bbrep.2016.01.001_bib30","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0169-5002(02)00013-2","article-title":"Expression of peroxisome proliferator activated receptor-gamma in non-small cell lung carcinoma: correlation with histological type and grade","volume":"36","author":"Theocharis","year":"2002","journal-title":"Lung Cancer"},{"key":"10.1016\/j.bbrep.2016.01.001_bib31","doi-asserted-by":"crossref","first-page":"8806","DOI":"10.1073\/pnas.95.15.8806","article-title":"Ligands for peroxisome proliferator-activated receptorgamma and retinoic acid receptor inhibit growth and induce apoptosis of human breast cancer cells in vitro and in BNX mice","volume":"95","author":"Elstner","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bbrep.2016.01.001_bib32","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1023\/A:1023366117157","article-title":"PPARgamma ligands and ATRA inhibit the invasion of human breast cancer cells in vitro","volume":"79","author":"Liu","year":"2003","journal-title":"Breast Cancer Res.Treat."},{"key":"10.1016\/j.bbrep.2016.01.001_bib33","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.bcp.2011.05.030","article-title":"Anticancer activity of thymoquinone in breast cancer cells: possible involvement of PPAR-\u03b3 pathway","volume":"82","author":"Woo","year":"2011","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bbrep.2016.01.001_bib34","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1016\/j.ajpath.2011.04.026","article-title":"In vivo and in vitro evidence that PPAR\u03b3 ligands are antagonists of leptin signaling in breast cancer","volume":"179","author":"Catalano","year":"2011","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bbrep.2016.01.001_bib35","doi-asserted-by":"crossref","first-page":"5743","DOI":"10.4049\/jimmunol.171.11.5743","article-title":"Peroxisome proliferator-activated receptor-gamma-deficient heterozygous mice develop an exacerbated neural antigen-induced Th1 response and experimental allergic encephalomyelitis","volume":"171","author":"Natarajan","year":"2003","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbrep.2016.01.001_bib36","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1172\/JCI13202","article-title":"Peroxisome proliferator-activated receptor-gamma haploinsufficiency enhances B cell proliferative responses and exacerbates experimentally induced arthritis","volume":"108","author":"Setoguchi","year":"2001","journal-title":"J. Clin. Investig."}],"container-title":["Biochemistry and Biophysics Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405580816000029?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405580816000029?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T07:39:09Z","timestamp":1762501149000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405580816000029"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":36,"alternative-id":["S2405580816000029"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrep.2016.01.001","relation":{},"ISSN":["2405-5808"],"issn-type":[{"value":"2405-5808","type":"print"}],"subject":[],"published":{"date-parts":[[2016,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A proline-type fullerene derivative inhibits adipogenesis by preventing PPAR\u03b3 activation","name":"articletitle","label":"Article Title"},{"value":"Biochemistry and Biophysics Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrep.2016.01.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}